3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
about
Psychedelics and the human receptoromeActions of N-arachidonyl-glycine in a rat inflammatory pain modelFatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedsideNeuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease.Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain modelConformationally constrained analogs of BAY 59-3074 as novel cannabinoid receptor ligands.(-)-Trans-Δ(9)-Tetrahydrocannabinol-Like Discriminative-Stimulus Effects of Gabapentin in Cannabis UsersSustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain.Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.Neuropathic pain: strategies in drug discovery and treatment.Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on MigraineEffects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain.Opioid and cannabinoid synergy in a mouse neuropathic pain model.A catalytic fluoride-rebound mechanism for C(sp3)-CF3 bond formation.Gαs signalling of the CB1 receptor and the influence of receptor number.Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.
P2860
Q21090031-08255988-1318-4405-992D-E4C302A97CD7Q27498684-166EC27C-8010-4F5C-9559-42709705F51DQ33560467-B652AC92-19B3-4EAA-9D95-BA3044772B5AQ33618200-5034433A-11BE-4C40-841B-8C4D6D70F5CFQ34019573-9A0D28B0-798B-4DE2-A75E-4E4D443F80CFQ34098292-8D1AA4D5-EA55-4212-969C-2D926CF262B1Q35545219-F9BF5EE8-F0AF-4677-BBA1-B89F26838D1AQ36015427-42E0DC4E-32D7-4BD7-854A-A1F7CB316DFEQ36341688-4B9E209C-2117-4257-8839-9C733B1CBF93Q36744213-FE560E44-E00C-4B11-86F1-571C94591E5EQ36956793-83C51353-35EE-42D3-8EDA-7D8A8C7ECEDFQ37058566-53B45696-6B71-468A-B4CA-D9895377032AQ37345025-5D0A4328-B64F-476B-9CAF-228B3E40068EQ37495207-F1C52BEC-F9E7-428C-876D-F9E087F0AED8Q38089846-D080EDF4-865A-4C68-A34B-3836BD78380EQ39778987-6FE9CC09-AE65-4A5C-8D84-D0D8948EA74DQ41572995-4A12FA1B-33E6-42EA-82D9-642F2DED13BCQ41692444-8976DB07-3909-4D0E-9C06-36454A251EBBQ42406036-3B5D5C2E-A1FF-48F1-BCC8-9ED204402C9BQ46626309-3902FC90-BC3E-4F05-809D-20FAFA977BC4Q48128574-803326C1-386D-4A3F-A4F9-1529A9BE9EDCQ52651312-9CF0BCE9-BB0C-411B-A885-A235E7379A88
P2860
3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
3-[2-cyano-3-(trifluoromethyl) ...... sic and antiallodynic effects.
@ast
3-[2-cyano-3-(trifluoromethyl) ...... sic and antiallodynic effects.
@en
3-[2-cyano-3-(trifluoromethyl) ...... sic and antiallodynic effects.
@nl
type
label
3-[2-cyano-3-(trifluoromethyl) ...... sic and antiallodynic effects.
@ast
3-[2-cyano-3-(trifluoromethyl) ...... sic and antiallodynic effects.
@en
3-[2-cyano-3-(trifluoromethyl) ...... sic and antiallodynic effects.
@nl
prefLabel
3-[2-cyano-3-(trifluoromethyl) ...... sic and antiallodynic effects.
@ast
3-[2-cyano-3-(trifluoromethyl) ...... sic and antiallodynic effects.
@en
3-[2-cyano-3-(trifluoromethyl) ...... sic and antiallodynic effects.
@nl
P2093
P921
P356
P1476
3-[2-cyano-3-(trifluoromethyl) ...... sic and antiallodynic effects.
@en
P2093
Dirk Denzer
Elke Reissmueller
Frank Mauler
Heinrich Meier
Jean De Vry
Markus Heil
Maud Eijckenboom
P304
P356
10.1124/JPET.103.062836
P407
P577
2004-05-12T00:00:00Z